Scaling cell therapy production workflows requires the establishment of closed, automated steps.
Evan Zynda
Advertisement
Evan Zynda, PhD, is senior scientist at Thermo Fisher Scientific.
Articles by Evan Zynda
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
5
